CureVac Files Routine 6-K Report
| Field | Detail |
|---|---|
| Company | Curevac N.V. |
| Form Type | 6-K |
| Filed Date | Jun 12, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 6-k, routine-report
TL;DR
CureVac filed a standard 6-K, no major news.
AI Summary
CureVac N.V. filed a Form 6-K on June 12, 2025, reporting for the month of June 2025. The filing is a report of a foreign private issuer and does not contain specific financial updates or material events beyond its routine reporting status.
Why It Matters
This filing indicates CureVac N.V. is fulfilling its regular reporting obligations as a foreign private issuer with the SEC.
Risk Assessment
Risk Level: low — This is a routine filing by a foreign private issuer and does not contain new material information or financial disclosures.
Key Players & Entities
- CureVac N.V. (company) — Registrant
- 001-39446 (company) — SEC File Number
- June 12, 2025 (date) — Filing Date
FAQ
What is the purpose of this Form 6-K filing?
This Form 6-K is a report of a foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, for the month of June 2025.
What is the company's SEC file number?
The company's SEC file number is 001-39446.
When was this filing submitted?
This filing was submitted on June 12, 2025.
What is the company's principal executive office address?
The company's principal executive office is located at Friedrich-Miescher-Strasse 15, 72076 Tübingen, Germany.
Does CureVac N.V. file annual reports under Form 20-F or Form 40-F?
CureVac N.V. files annual reports under Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on June 12, 2025 regarding CureVac N.V..